Do you want to read an article? Please log in or register.
Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis
Systemic Sclerosis
Related content
Autoimmune Disease
Effectiveness and safety of rituximab for the treatment of refractory systemic sclerosis associated calcinosis: A case series and systematic review of the literature
Autoimmun Rev.
Narváez J, Pirola JP, LLuch J, Juarez P, Nolla JM, Valenzuela A
doi: 10.1016/j.autrev.2018.10.006.
Systemic Sclerosis
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial
Ann Rheum Dis.
Khanna D, Allanore Y, Denton CP, Kuwana M, Matucci-Cerinic M, Pope JE, Atsumi T, Bečvář R, Czirják L, Hachulla E, Ishii T, Ishikawa O, Johnson SR, De Langhe E, Stagnaro C, Riccieri V, Schiopu E, Silver RM, Smith V, Steen V, Stevens W, Szücs G, Truchetet ME, Wosnitza M, Laapas K, de Oliveira Pena J, Yao Z, Kramer F, Distler O
doi: 10.1136/annrheumdis-2019-216823.
Psoriasis
Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR)
J Am Acad Dermatol.
Strober B, Gooderham M, de Jong EMGJ, Kimball AB, Langley RG, Lakdawala N, Goyal K, Lawson F, Langholff W, Hopkins L, Fakharzadeh S, Srivastava B, Menter A
doi: 10.1016/j.jaad.2017.08.051.
Further Publications Dermatology
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial
JAMA
Wang X, Wang SS, Huang H, Cai L, Zhao L, Peng RJ, Lin Y, Tang J, Zeng J, Zhang LH, Ke YL, Wang XM, Liu XM, Chen QJ, Zhang AQ, Xu F, Bi XW, Huang JJ, Li JB, Pang DM, Xue C, Shi YX, He ZY, Lin HX, An X, Xia W, Cao Y, Guo Y, Su YH, Hua X, Wang XY, Hong RX, Jiang KK, Song CG, Huang ZZ, Shi W, Zhong YY, Yuan ZY, South China Breast Cancer Group (SCBCG).
doi: 10.1001/jama.2020.23370
Rheumatoid ArthritisSystemic Sclerosis
Effect of combined pulmonary fibrosis and emphysema on patients with connective tissue diseases and systemic sclerosis: a systematic review and meta-analysis
Arthritis Res Ther
Koo BS, Park KY, Lee HJ, Kim HJ, Ahn HS, Yim SY, Jun JB
doi: 10.1186/s13075-021-02494-y
Systemic Sclerosis
Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis
Rheumatology (Oxford).
Nevskaya T, Zheng B, Baxter CA, Ramey DR, Pope JE, Baron M
doi: 10.1093/rheumatology/kez529.
Systemic Sclerosis
Dipeptidyl-peptidase-4 as a marker of activated fibroblasts and a potential target for the treatment of fibrosis in Systemic Sclerosis
Arthritis Rheumatol.
Soare A, Györfi HA, Matei AE, Dees C, Rauber S, Wohlfahrt T, Chen CW, Ludolph I, Horch RE, Bäuerle T, von Hörsten S, Mihai C, Distler O, Ramming A, Schett G, Distler JHW
doi: 10.1002/art.41058.
COMMENTED
Systemic Sclerosis
Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)
★ 3
Recommended and commented by
Dr Heino Prillwitz, Faculty Member
Arthritis Res Ther.
Pan Z, Marra AM, Benjamin N, Eichstaedt CA, Blank N, Bossone E, Cittadini A, Coghlan G, Denton CP, Distler O, Egenlauf B, Fischer C, Harutyunova S, Xanthouli P, Lorenz HM, Grünig E
doi: 10.1186/s13075-019-1981-0.
Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials.
JAMA.
Khanna D, Denton CP, Merkel PA, Krieg T, Le Brun FO, Marr A, Papadakis K, Pope J, Matucci-Cerinic M, Furst DE; DUAL-1 Investigators; DUAL-2 Investigators
doi: 10.1001/jama.2016.5258.